TY - JOUR T1 - Introducing the 4Ps Model of Transitioning to Distance Learning: a convergent mixed methods study conducted during the COVID-19 pandemic JF - medRxiv DO - 10.1101/2021.03.23.21254165 SP - 2021.03.23.21254165 AU - Farah Otaki AU - Shroque Zaher AU - Stefan Du Plessis AU - Ritu Lakhtakia AU - Nabil Zary AU - Ibrahim Inuwa Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/24/2021.03.23.21254165.abstract N2 - Significant concern has been raised regarding the effect of COVID-19 on medical education. The aim of this study was to shed light on the distance learning experiences of medical students and their instructors. A convergent mixed methods approach was utilized. Qualitative and quantitative data was collected using a survey.The percentage of the total average of satisfaction among stakeholders was 76.4%. The qualitative analysis revealed several themes. This study introduced the 4Ps Model of Transitioning to Distance Learning. It would be useful to leverage the lessons-learned to tailor blended medical programs, with a reasonable mélange of experiences. The study also contributes to the mixed methods research through showcasing a means of adapting it to evaluate critical situations reliably and rapidly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research work did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was granted by the MBRU, Institutional Review Board (Reference # MBRU-IRB-2020-032).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript is available with the corresponding author and can be shared upon request. ER -